Cover Story
At its most recent meeting, in July 2015, the FDA Oncologic Drugs Advisory Committee voted…
By Matthew Bin Han Ong
In Brief
Trending Stories
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Beyond the $500B Stargate Project: The frontier of AI in oncology beckons
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Tracking Trump’s early impact on cancer policy
Research and care disrupted, NCI programs face unpredictable future - Felix Feng, GU cancer researcher who made fundamental discoveries in genomics, dies at 48
- Trump 2016: A look back at the 45th president’s impact on oncology